UAB Digital Repository of Documents 1 records found  Search took 0.02 seconds. 
1.
11 p, 1.1 MB Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain / Casado, Enrique (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Rosas, José (Hospital Marina Baixa (La Vila Joiosa, Alacant)) ; Rubio-Terrés, Carlos (Health Value) ; Rubio-Rodríguez, Darío (Health Value) ; Boolell, Mitra (Medical Affairs) ; Arístegui, Ignacio (Medical Affairs) ; Universitat Autònoma de Barcelona
To estimate the cost-effectiveness of treating postmenopausal osteoporosis (PMO) with weekly gastro-resistant risedronate 35 mg gastro-resistant tablets (RIS-GR), compared with weekly alendronate 70 mg tablets (ALN) in Spain. [...]
2023 - 10.57264/cer-2023-0115
Journal of Comparative Effectiveness Research, Vol. 12 (september 2023)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.